Circulating CTRP1 Levels Are Increased and Associated with the STOD in Essential Hypertension in Chinese Patients

Table 1

Clinical and biochemical characteristics of hypertension group and control group (x±s).

Indicator	Hypertension group (n=360)	Control; Group (n=360)	χ^2/t; value	P value
Age	58.27±15.08	58.91±13.16	-0.600	0.548
Gender			0.358	0.549
Female	168(46.7)	160(44.4)
Male	192(53.3)	200(55.6)
SBP(mmHg)	150.29±9.83	116.73±10.56	44.117	0.001
DBP(mmHg)	79.97±11.42	70.00±7.06	14.090	0.001
BMI(kg/m2)	24.47±3.38	23.82±2.42	2.978	0.003
FGLU(mmol/L)	5.49±0.93	5.36±0.80	2.043	0.041
FIN(mIU/L)	11.48±1.78	11.50±1.88	-0.156	0.876
HOMA	1.96±0.58	1.93±0.41	0.857	0.392
TC(mmol/L)	4.74±1.03	4.63±1.19	1.250	0.212
TG(mmol/L)	1.85±0.59	1.61±0.44	6.108	0.001
LDL(mmol/L)	3.20±0.84	2.79±0.81	6.617	0.001
HDL(mmol/L)	1.09±0.27	1.24±0.33	-6.702	0.001
CRP(mg/L)	7.20±2.14	6.16±1.31	7.850	0.001
LVMI(gym2)	116.82±18.30	83.71±24.83	20.365	0.001
UACR(mg/mmol)	2.25±0.64	1.53±0.47	17.227	0.001
APN(mg/L)	6.44±1.67	9.91±1.97	-25.554	0.001
CTRP1(ug/L)	11.70±3.09	8.22±1.41	19.456	0.001
TNFa(ng/L)	66.44±22.81	35.24±3.75	25.609	0.001
IL6(ng/L)	21.54±5.76	14.34±2.02	22.356	0.001